- Drugs
- Wednesday, 18 Dec 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
"Brooke's contributions to the Company have been extraordinary," said Medical Marijuana, Inc. COO Blake Schroeder. "He's helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency."
Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company's accounting department, handling the Company's budget management, public financial reports, e-commerce offerings, and forecasting needs.
"Working with the Medical Marijuana, Inc. team has been an incredibly rewarding experience," said Beers. "Last December, the Brightfield Group reported that our Company represents 10 percent of the entire CBD market and I'm proud to be a part of that financial milestone and many more to come. It's encouraging to work with a large group of highly motivated professionals and claim our stake in the global CBD industry."
Related Industry Updates
Diabetic Foot Ulcer Market is expected to reach US$ 12,242.77 million by 2030
Sep 14, 2023
OTC Drug and Dietary Supplement Market In-depth Research Analysis By The Insight Partners
Jan 05, 2021
Enteral and Parenteral Medical Nutrition Market is expected to reach US$ 25,476.86 million by 2028
Jun 15, 2023
CRO industry faces consolidation
Sep 04, 2019
Pre Clinical CROs Market Real Time Analysis and Forecast 2021–2027 | Key Companies: WuXi AppTec Group , Medpace, Inc. , Pharmaceutical Product Development, LLC , Parexel International , ICON plc , MD Biosciences, Inc., etc
May 03, 2021
Cannabis Market is expected to reach US$ 1,99,504.9 million by 2028
Jan 31, 2023
Europe Small Molecule Drug Delivery Market Opportunity Assessment and Forecast up to 2027
Sep 05, 2020